share_log

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmicals 已在馬薩諸塞州綜合醫院招收了第一位參與者 TNX-1900(鼻內增強催產素)治療兒科肥胖症的 “POWER” 第二階段 “POWER” 研究
Benzinga ·  2023/07/10 07:06

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmicals 已在馬薩諸塞州綜合醫院招收了第一位參與者 TNX-1900(鼻內增強催產素)治療兒科肥胖症的 “POWER” 第二階段 “POWER” 研究

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論